LILRB4 and exocrine pancreatic carcinoma: Soluble LILRB4 has been found in the serum of pancreatic carcinoma, colorectal carcinoma, and melanoma patients, and T cell responses are increased in vitro upon treatment with anti-LILRB4 antibody (Suciu-Foca et al., 2007).